Top Markets
Coin of the day
Medeon Biodesign, Inc. Medeon Biodesign, Inc.

Medeon Biodesign, Inc.

6499
Rang in aandelen #17677
Medeon Biodesign, Inc. engages in the research and development, manufacturing,... Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, a solution to view throughout laparoscopic surgeries; and AbClose to prevent port site herniation caused by improper closure. It is engaged in the medical device contract manufacturing; and manufacture and sale of injection molding and components of medical devices. Medeon Biodesign, Inc. was incorporated in 2012 and is based in Taipei, Taiwan.
Aandeelprijs
$2.38
Laatst gesynchroniseerd: 2026-09-02
Marktkapitalisatie
$231.21M
Verandering (1 dag)
0.94%
Verandering (1 jaar)
-20.92%
Land
TW
Handel Medeon Biodesign, Inc. (6499)

Categorie

Dividendrendementgeschiedenis voor Medeon Biodesign, Inc. (6499)
Het dividendrendement (TTM) van Medeon Biodesign, Inc. (aandelsymbool: 6499) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Medeon Biodesign, Inc. (6499) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten